1.
Southeast Asian J Trop Med Public Health
;
1991 Mar; 22(1): 39-40
Artigo
em Inglês
| IMSEAR
| ID: sea-34987
RESUMO
The immunogenecity of a recombinant yeast-derived hepatitis B vaccine in 25 premature infants who were born to HBsAg negative mothers was studied. The gestational ages were 28-37 weeks and birth weights were 1300-2000 grams. Seroconversion occurred in 22 infants, the anti HBs titers varied between 50 and 13,470 IU/L (Geometric mean titer = 542 IU/L). Seroconversion rate = 88%. The response did not vary with gestational age, birth weight or illness status.
Assuntos
Anticorpos Anti-Hepatite B/biossíntese , Antígenos de Superfície da Hepatite B/imunologia , Vacinas contra Hepatite B , Humanos , Recém-Nascido , Recém-Nascido Prematuro/imunologia , Vacinas Sintéticas/administração & dosagem , Vacinas contra Hepatite Viral/administração & dosagem
2.
Artigo
em Inglês
| IMSEAR
| ID: sea-42267